These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11476960)

  • 1. Cholera toxin-induced PGE(2) activity is reduced by chemical reaction with L-histidine.
    Peterson JW; King D; Ezell EL; Rogers M; Gessell D; Hoffpauer J; Reuss L; Chopra AK; Gorenstein D
    Biochim Biophys Acta; 2001 Jul; 1537(1):27-41. PubMed ID: 11476960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterotoxin-induced fluid accumulation during experimental salmonellosis and cholera: involvement of prostaglandin synthesis by intestinal cells.
    Duebbert IE; Peterson JW
    Toxicon; 1985; 23(1):157-72. PubMed ID: 2986318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins.
    Kimberg DV; Field M; Johnson J; Henderson A; Gershon E
    J Clin Invest; 1971 Jun; 50(6):1218-30. PubMed ID: 4325309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E in cholera toxin-induced intestinal secretion. Lack of an intermediary role.
    Hudson N; Hindi SE; Wilson DE; Poppe L
    Am J Dig Dis; 1975 Nov; 20(11):1035-9. PubMed ID: 173182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of 5-hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo.
    Beubler E; Kollar G; Saria A; Bukhave K; Rask-Madsen J
    Gastroenterology; 1989 Feb; 96(2 Pt 1):368-76. PubMed ID: 2535994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of intestinal mediators in the mode of action of cholera toxin.
    Peterson JW; Lu Y; Duncan S; Cantu J; Chopra AK
    J Med Microbiol; 1994 Jul; 41(1):3-9. PubMed ID: 8006942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum.
    Beubler E; Schuligoi R; Chopra AK; Ribardo DA; Peskar BA
    J Pharmacol Exp Ther; 2001 Jun; 297(3):940-5. PubMed ID: 11356914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prostaglandins and cholera enterotoxin on intestinal mucosal cyclic AMP accumulation. Evidence against an essential role for prostaglandins in the action of toxin.
    Kimberg DV; Field M; Gershon E; Henderson A
    J Clin Invest; 1974 Mar; 53(3):941-9. PubMed ID: 4359941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tropisetron, a 5-hydroxytryptamine type 3 receptor blocker, on intestinal secretion induced by cholera toxin or deoxycholic acid in rabbits in vivo.
    Bardhan PK; Rahman AS; Islam S; Rahman M; Gyr K
    J Int Med Res; 1993; 21(6):323-33. PubMed ID: 8143887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mediators formed in the small intestine in response to cholera toxin.
    Peterson JW; Cantu J; Duncan S; Chopra AK
    J Diarrhoeal Dis Res; 1993 Dec; 11(4):227-34. PubMed ID: 8188995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prostaglandins and cAMP in the secretory effects of cholera toxin.
    Peterson JW; Ochoa LG
    Science; 1989 Aug; 245(4920):857-9. PubMed ID: 2549637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of indomethacin on intestinal secretion, prostaglandin E and cyclic AMP: evidence against a role for prostaglandins in cholera toxin-induced secretion.
    Wilson DE; El-Hindi E; Tao P; Poppe L
    Prostaglandins; 1975 Oct; 10(4):581-7. PubMed ID: 172982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in cyclic 3'5'-adenosine monophosphate tissue concentration and net fluid transport in the cat's small intestine elicited by cholera toxin, arachidonic acid, vasoactive intestinal polypeptide and 5-hydroxytryptamine.
    Eklund S; Brunsson I; Jodal M; Lundgren O
    Acta Physiol Scand; 1987 Jan; 129(1):115-25. PubMed ID: 3031931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to reverse cholera toxin induced intestinal secretion by agents which decrease mucosal cAMP.
    Forsyth GW; Hamilton DL; Scoot A; Goertz KE; Kapitany RA
    Can J Physiol Pharmacol; 1979 Sep; 57(9):1004-10. PubMed ID: 229947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory and antisecretory potential of histidine in Salmonella-challenged mouse small intestine.
    Peterson JW; Boldogh I; Popov VL; Saini SS; Chopra AK
    Lab Invest; 1998 May; 78(5):523-34. PubMed ID: 9605177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and reversal of cholera enterotoxin effects in rabbit jejunum by nicotinic acid.
    Turjman N; Gotterer GS; Hendrix TR
    J Clin Invest; 1978 May; 61(5):1155-60. PubMed ID: 207728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholera-induced mucin secretion from rat intestine: lack of effect of cAMP, cycloheximide, VIP, and colchicine.
    Roomi N; Laburthe M; Fleming N; Crowther R; Forstner J
    Am J Physiol; 1984 Aug; 247(2 Pt 1):G140-8. PubMed ID: 6087674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholera enterotoxin on ion transport across isolated ileal mucosa.
    Field M; Fromm D; al-Awqati Q; Greenough WB
    J Clin Invest; 1972 Apr; 51(4):796-804. PubMed ID: 4335444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin.
    Thielman NM; Marcinkiewicz M; Sarosiek J; Fang GD; Guerrant RL
    J Clin Invest; 1997 Apr; 99(8):1999-2004. PubMed ID: 9109445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H
    Sousa FBM; Souza LKM; Sousa NA; Araújo TSL; de Araújo S; Pacífico DM; Silva IS; Silva RO; Nicolau LAD; Souza FM; Filgueiras MC; Oliveira JS; Souza MHLP; Medeiros JVR
    Nitric Oxide; 2018 Jun; 76():152-163. PubMed ID: 28943473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.